This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

United States Hospital Supplies Market Outlook To 2018 - Disposable Hospital Supplies, Mobility Aids And Transportation Equipment, Operating Room Equipment, Sterilization And Disinfectant Equipment And Others

13.1.4 Oct 03, 2012: Argo Medical Plans To Open Its US Headquarters In Marlborough 183

13.1.5 Oct 01, 2012: Johnson & Johnson Expands Operations In Puerto Rico 183

13.1.6 Sep 28, 2012: Sigma-Aldrich Invests In Scotland 183

13.1.7 Sep 24, 2012: Medline To Build New Medical Supply Distribution Center In Maumelle, Arkansas 184

13.1.8 Sep 03, 2012: Arthrex Continues Expansion Into Southwest Florida 185

13.1.9 Aug 01, 2012: Baxter Breaks Ground On $1 Billion Manufacturing Plant In Georgia, US 185

13.1.10 Jun 22, 2012: Stryker To Shut Down Facilities In Orchard Park And West Seneca 185

13.1.11 May 18, 2012: Midmark Announces Plans For Expansion And New Offices 186

13.1.12 May 10, 2012: C R Bard Creates 200 New Jobs Through Puerto Rican Expansion 187

13.1.13 Apr 05, 2012: Owen Mumford Establishes New Office In China 187

13.1.14 Jan 31, 2012: Boston Scientific Announces New Asia-Pacific Organization 187

13.1.15 Jan 21, 2012: CareFusion Opens Middle East Office In Dubai 188

13.1.16 Jan 19, 2012: BD And Mercy/ROi Collaborate To Improve Quality Of Care And Reduce Costs 188

13.2 Legal and Regulatory 190

13.2.1 Dec 20, 2012: Invacare Reaches Agreement With FDA On Terms Of Consent Decree, Subject To Approval Of US District Court 190

13.2.2 Nov 13, 2012: Integra LifeSciences' UK Manufacturing Facility Receives Warning Letter From FDA 192

13.2.3 Oct 16, 2012: KFx Medical Receives Favorable Markman Claim Construction Ruling In Patent Infringement Case Against Arthrex 192

13.2.4 Aug 23, 2012: United Drug Files Motion To Dismiss Legal Action By Catalent Pharma 193

7 of 14

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,677.90 +216.58 1.32%
S&P 500 1,950.82 +23.71 1.23%
NASDAQ 4,452.7920 +69.9450 1.60%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs